03/11/2020
Message us today to learn about the services we offer CBD and h**p manufacturers to take the guess work out of being compliant from the get go.
A little CBD news from the Federal Side...
Report to the U.S. House Committee on Appropriations and the U.S. Senate Committee on Appropriations | Cannabidiol (CBD) | Report in Response to Further Consolidated Appropriations Act, 2020 U.S. Food and Drug Administration
Dietary Supplements
Under current law, CBD products cannot lawfully be sold as dietary supplements, but FDA has
the authority to remove this exclusion through rulemaking….
V**e Products
FDA is aware that v**e products can be used for the inhalation of a variety of substances,
including CBD. FDA is concerned that CBD v**es pose public health risks in that va**ng CBD
raises toxicity concerns — both inherent to the substance and due to potential contaminants —
and could attract children and adolescents, which are vulnerable populations.
In addition to our general public health concerns about va**ng and CBD, we note that CBD containing
v**e products meeting the definition of to***co products will be regulated by FDA as
such – meaning, among other things, that they cannot be marketed without FDA pre-market
authorization. CBD-containing v**e products that are intended for use as a drug, by definition,
cannot be to***co products and are regulated as drugs — meaning, among other things, that they
cannot be marketed without FDA-approved drug applications.
More safety data and research are needed on this route of administration and potential
implications for local and systemic effects.
